PI 3-kinase; Na ϩ -K ϩ -ATPase; receptor recruitment THE POLYPEPTIDE HORMONE PROLACTIN (PRL) is involved in various actions in the body, including lactation, angiogenesis, and osmoregulation (12) . In a recent study, we found that prolactin had a natriuretic effect, which was associated with a profound inhibitory effect on proximal convoluted tubular (PCT) Na ϩ -K ϩ -ATPase activity. The natriuretic response to PRL as well as its effect on Na ϩ -K ϩ -ATPase activity were abolished by a dopamine 1 (D1)-like receptor antagonist. In addition, during inhibition of intrarenal dopamine production, the effect of PRL on Na ϩ -K ϩ -ATPase activity was blunted (17) . The prolactin receptor (PRLR) is a highly specific, highaffinity, membrane-anchored protein (5) . Several isoforms of PRLR exist, and we have identified the long and the medium short isoforms in rat renal cortex (17) . Activation of PRLR involves ligand-induced receptor dimerization, activation of the tyrosine kinase JAK-2, and tyrosine phosphorylation of several cellular proteins (5, 12) .
Dopamine has a central role in the interactive regulation of renal tubular sodium reabsorption. By its capacity to counteract the effect of antinatriuretic substances and act permissively for other natriuretic substances, intrarenal dopamine coordinates the effect of several sodium-regulating factors (15) . Permissive and synergistic effects between dopamine and atrial natriuretic peptide (ANP) and between dopamine and isoproterenol (7, 14) can be attributed to heterologous recruitment of D1-like receptors to the plasma membrane.
Dopamine signaling pathways in renal PCT include PKAand PKC-induced phosphorylation of Na ϩ -K ϩ -ATPase, as well as induction of a coimmunoprecipitation of Na ϩ -K ϩ -ATPase and phosphoinositide 3-kinase (PI 3-K) (4, 9, 11, 29) .
In this study, we have explored the molecular mechanisms by which dopamine and PRL exert their synergistic/permissive function and tested whether these mechanisms may be perturbed in a rat model of hypertension.
MATERIALS AND METHODS

Animals.
The study was performed in male Sprague-Dawley (SD) rats (B & K Universal, Sollentuna, Sweden), spontaneously hypertensive rats (SHR), and its normotensive control, Wistar-Kyoto rats (WKY), aged 40 -50 days and weighing between 200 and 250 g. All animals had free access to tap water and were fed ad libitum with standard rat chow (R3, Ewos, Södertälje, Sweden) containing 0.3% sodium, 0.8% potassium, and 21% protein. All experiments were performed according to the Karolinska Institutet regulations concerning care and use of laboratory animals and approved by the Stockholm North ethical evaluation board for animal research.
Preparation of PCT segments. Kidney perfusion and tubule microdissection were performed as described (14) in all three rat strains. The rats were anesthetized with an intraperitoneal injection of Mebumal vet (5-6 mg/100 g body wt, Nord Vacc, Stockholm, Sweden). Following an abdominal midline incision, the left kidney was exposed and perfused with a cold, modified Hanks' solution containing 0.05% collagenase (Sigma, St. Louis, MO) and 0.1% BSA (Behringwerke, Marburg, Germany). The pH was adjusted to 7.4. The kidney was removed and cut along its corticopapillary axis into small pyramids that were incubated for 20 min at 35°C in a perfusion solution containing 10 Ϫ3 M butyrate to optimize mitochondrial respiration. The solution was continuously bubbled with oxygen. After incubation, the tissue was rinsed with fresh microdissection solution, which had the same composition as the perfusion solution except that the CaCl 2 concentration was 0.25 mM and collagenase and BSA were omitted.
The single PCT segments were manually dissected (tubular segment length 0.4 -1.1 mm) from the outer cortex under a stereomicroscope at 4°C. By this technique, a homogenous preparation of proximal tubular cells were obtained. The tubule segments were individually transferred to the concavity of a bacteriological slide in a drop of the microdissection solution and photographed for length determination using an inverted microscope at ϫ100 magnification. Tubules were stored on ice until dissection was completed, for a maximum of 30 -60 min.
Preincubation of tubules with different drugs. Tubule segments were incubated at indicated times at room temperature (RT), either in 1 l of microdissection solution alone (control tubules) or in 1 l of microdissection solution containing one or more of the indicated agents (experimental tubules).
Determination of Na ϩ -K ϩ -ATPase activity. The preincubation period was stopped by cooling the tubular segments at 4°C. The segments were made permeable by repeated freezing and thawing. This procedure allows ATP and sodium free access to the interior of the cell. The tubules were incubated at 37°C for 15 min in a medium containing (in mM) 70 NaCl, 5 KCl, 10 MgCl 2, 1 EGTA, 100 Tris · HCl, and 10 Tris-ATP, and ␥-[ 32 P]ATP (NEN, Boston, MA); 2-5 Ci/mmol in trace amounts (5 nCi/ml). For determination of ouabain-insensitive ATPase activity, 2 mM ouabain (USB, Cleveland, OH) was added, NaCl and KCl were omitted, and Tris · HCl was 150 mM. The 32 P-labeled phosphate liberated by hydrolysis of ATP was separated by filtration through a Millipore filter after absorption of the unhydrolyzed nucleotide on activated charcoal, and radioactivity was counted in a liquid scintillation spectrometer.
In each study, total ATPase activity and ouabain-insensitive ATPase activity were measured on each of five to eight other tubule segments. Na ϩ -K ϩ -ATPase activity (pmol of 32 Pi hydrolyzed per mm of tubule length per hour) was calculated as the difference between the mean value for total ATPase and ouabain-insensitive ATPase activity and expressed as an absolute value. Control and experimental tubules were always run in parallel.
Antibodies. PKC-dependent phosphorylation of Na ϩ -K ϩ -ATPase was identified by a rat anti-PKC dephosphospecific antibody (McK1; a kind gift from Dr. K. J. Sweadner). This antibody recognizes Ser-23 (Ser-18 in some literature)-dephosphorylated Na ϩ -K ϩ -ATPase ␣-subunit (10). Na ϩ -K ϩ -ATPase was detected by anti-mouse Na ϩ -K ϩ -ATPase ␣1 antibody (Upstate, Lake Placid, NY).The D1-like receptor was detected by a noncommercial primary affinity-purified anti-rabbit D1 receptor antibody (26) . The PI 3-K antibody used was anti-PI 3-kinase p85␣ (Z-8) from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase-conjugated anti-rat, anti-rabbit, and anti-mouse (Amersham Biosciences, Piscataway, NJ), respectively, were used as secondary antibodies. Immunoreactivity was detected using an enhanced chemiluminescence plus Western blotting detection system (Amersham Biosciences, Uppsala, Sweden). Molecular size determinations were made using prestained SDS-PAGE standards (Bio-Rad Laboratories).
Western blotting, immunoprecipitation, and biotinylation. Immediately after the animals were euthanized, 250-m slices were taken from the outer renal cortex using a microtome. The outer 250-m region of rat renal cortex contains Ͼ90% proximal tubule cells (2) . In some protocols, the slices were used for coimmunoprecipitation studies. In the biotinylation protocol, the slices were used for preparation of primary cultures of renal proximal tubule cells. Renal proximal tubule cells were prepared as described previously (22, 23) . Briefly, the cells were cultured in supplemented DMEM (20 mM HEPES/24 mM NaHCO3/10 g/ml penicillin/10 g/ml streptomycin/10% FBS) on petri dishes for 48 h in 5% CO2 at 37°C.
PKC-dependent phosphorylation of Na ϩ -K ϩ -ATPase. Outer cortical slices dissected from rat kidneys were kept in ice-cold buffer containing (in mM) 70 NaCl, 5 KCl, 10 MgCl2, 1 EGTA, 100 Tris · HCl, and 1 n-butyric acid. The cortical slices were incubated with vehicle, PRL 1 g/ml (Sigma), dopamine (10 Ϫ5 M), or dopamine and AG 490 (10 Ϫ5 M) for 15 min in the buffer medium at RT. When used, the cells were preincubated with AG 490 for 10 min. After drug treatment, the medium was aspirated and tissue slices were immediately frozen. The slices were then thawed and homogenized in RIPA buffer containing 50 mM Tris · HCl (pH 7.4), 50 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, 0.5% Nonidet P-40, and protease inhibitors (Roche Diagnostics) and centrifuged at 9,000 g for 20 min at 4°C. Supernatant protein concentration was measured by Bio-Rad DC protein assay (Bio-Rad). A total protein of 10 g/well was eluted with 2ϫ Laemmli sample buffer and resolved in 8% polyacrylamide gels by SDS-PAGE, transferred to a polyvinylidene difluoride membrane (Hybond-P, Amersham Biosciences, Uppsala, Sweden), and immunoblotted with Na ϩ -K ϩ -ATPase ␣1 or McK1 antibodies. The proteins were visualized with chemiluminescence using secondary antibodies labeled with horseradish peroxidase (GE Healthcare) and enhanced chemiluminescence (GE Healthcare). Prestained SDS-PAGE standards were used for size determination (Bio-Rad Laboratories, Sundbyberg, Sweden).
Renal cortical slices isolated from SD rats were treated with PRL for 3 min or the D1-like receptor agonist SKF S-143 (10 Ϫ5 M, Sigma) for 10 min at 37°C in a treatment buffer containing (in mM) 124 NaCl, 4 K, 26 NaHCO3, 10 D-glucose, 1.5 MgSO4, 1 n-butyric acid, 1.5 CaCl2, and 0.25 KH2PO4. When used, the D1-like receptor antagonist SCH 23390 (10 Ϫ6 M) was preincubated for 10 min. After drug treatment, the medium was aspirated and tissue slices were immediately frozen. The slices were then thawed and homogenized in a buffer containing 65 mM Tris base, 154 mM NaCl, 6 mM sodium deoxycholate, 1 mM EDTA, 10% NP-40, 1 mM DTT, and complete protease inhibitor (Roche Diagnostics), pH 7.4, and centrifuged at 9,000 g for 20 min at 4°C. Supernatant protein concentration was measured by Bio-Rad DC protein assay (Bio-Rad Laboratories), and the samples were adjusted to equal amounts. Tissue lysates from vehicle-or drug-treated groups were incubated for 1 h at 4°C with Na ϩ -K ϩ -ATPase ␣1 antibody with mouse IgG as a control. Immunocomplexes were then incubated with protein G-Sepharose beads (GE Healthcare) overnight at 4°C. After the beads were washed three times with RIPA buffer, the proteins were eluted with sample buffer and resolved by Western blotting. PI 3-K was detected by anti-PI 3-K p85␣.
Subcellular fractionation. Briefly, cortical renal slices from SD rats were incubated with PRL (1 g/ml) for 15 min in the treatment buffer above. The treatment was stopped by a rapid freezing procedure on dry ice. After thawing, the renal slices were homogenized in Harm's buffer containing (in mM) 250 sucrose, 10 triethanolamine, 10 acetic acid, and 1 EDTA, pH to 7.45. The samples were centrifuged for 1 min with a table centrifuge to get rid of cell debris. The supernatant was subjected to centrifugation at 20,000 g for 30 min. The resultant pellet, considered as the plasma membrane-containing fraction, and the resultant supernatant were adjusted to equal protein amounts, eluted with Laemmli buffer, and resolved by Western blotting. As demonstrated in Fig. 4A , the plasma membrane protein Na ϩ -K ϩ -ATPase was enriched in the pellet, confirming that this fraction contains plasma membrane.
Biotinylation. Cultured renal proximal tubule cells were incubated with either vehicle (DMEM) or PRL (final concentration 1 g/ml) for 10 min at 37°C. Surface membrane proteins were biotinylated by exposing cells to EZ-linked Sulfo-NHS-SS Biotin (Pierce), at a final concentration of 1 mg/ml in PBS at 4°C for 2 h. The cells were carefully washed three times with PBS and lysed in ice-cold lysis buffer containing 50 mM Tris · HCl (pH 7.4), 50 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, 0.5% Nonidet P-40, and protease inhibitors, (Roche Diagnostics), and the lysate was centrifuged at 14,000 g for 10 min at 4°C. After centrifugation, the supernatant was saved and protein was adjusted to an equal amount according to the Bio-Rad DC protein assay. Biotinylated proteins were captured with 100 l of streptavidin-agarose beads (Pierce immobilized streptavidin, 6% beaded agarose) overnight at 4°C with end-to-end mixing. Pellets recovered after centrifugation at 14,000 g for 10 min at 4°C were washed twice with PBS. Proteins were eluted with Laemmli buffer, heated to 70°C for 15 min, and resolved by Western blotting.
Statistical analysis. Values are expressed as means Ϯ SE. Statistical analysis was performed using Student's t-test with one-way ANOVA.
RESULTS
Signaling pathways. The dopamine-induced decrease in PCT Na ϩ -K ϩ -ATPase activity is mediated by PKA-and PKCdependent phosphorylation of Na ϩ -K ϩ -ATPase (4, 11). PRL (1 g/ml) decreased PCT Na ϩ -K ϩ -ATPase activity. This effect was completely abolished by a specific inhibitor of PKA, H89 (3 ϫ 10 Ϫ5 M), as well as by a specific inhibitor of PKC, bisindolyl maleic acid (BIM; 10 Ϫ6 M) (Fig. 1) . When added alone, neither H89 nor BIM had any significant effect on the Na ϩ -K ϩ -ATPase activity (data not shown). The PRLR activates Janus kinase 2 (JAK-2), which is specifically inhibited by AG-490 (5, 12). AG-490 (10 Ϫ5 M) significantly reduced the PRL-induced decrease in PCT Na ϩ -K ϩ -ATPase activity. AG-490 had no effect on the dopamine-induced decrease in PCT Na ϩ -K ϩ -ATPase activity (Fig. 1) . AG-490 alone had no effect on basal Na ϩ -K ϩ -ATPase activity (data not shown). Ouabaininsensitive Na ϩ -K ϩ -ATPase activity was not affected by any drugs added (data not shown).
Dopamine, via PKC, phosphorylates the Ser-23 residue in the N-terminus of the rat ␣-subunit rat of Na ϩ -K ϩ -ATPase (4, 10). The PKC phosphorylation of Na ϩ -K ϩ -ATPase was visualized using a monoclonal antibody (McK1) which detects Ser-23-dephosphorylated Na ϩ -K ϩ -ATPase ␣-subunit (10). In isolated renal cortical slices, PRL (1 g/ml) reduced the amount of dephosphorylated Na ϩ -K ϩ -ATPase without any effect on the total amount of Na ϩ -K ϩ -ATPase ( Fig. 2A ), resulting in a significantly reduced ratio between dephosphorylated and total Na ϩ -K ϩ -ATPase compared with control (control: 0.93 Ϯ 0.17; PRL 0.27 Ϯ 0.08; P Ͻ 0.05, n ϭ 7). We have previously used the same antibody to demonstrate that dopamine has a similar effect and reduces the amount of dephosphorylated Na ϩ -K ϩ -ATPase (18). For comparison, Fig (Fig.  1 ). Wortmannin added alone had no effect on Na ϩ -K ϩ -ATPase activity (data not shown). In the presence of PRL (1 g/ml), the p85 ␣-subunit-SH3 domain of PI 3-K coimmunoprecipitated with the Na ϩ -K ϩ -ATPase ␣-subunit. This effect was abolished by the D1-like receptor antagonist SCH 23390 (Fig.  2B) . The D1-like receptor agonist SKF S-143 significantly enhanced the interaction between PI 3-K and Na
Permissive and synergistic effects. Dopamine and PRL dose dependently decrease PCT Na ϩ -K ϩ -ATPase activity. Maximal effects are seen at 10 Ϫ5 M dopamine and 1 g/ml PRL (1, 17) . PRL (1 g/ml) decreased PCT Na ϩ -K ϩ -ATPase activity to 48 Ϯ 3% of control, whereas dopamine (10 Ϫ5 M) decreased PCT Na ϩ -K ϩ -ATPase activity to 63 Ϯ 4% of control (P Ͻ 0.0005) (Fig. 3A) . Subthreshold doses of PRL (1 ng/ml) and dopamine (5 ϫ 10 Ϫ8 M) had no effect added separately, but added together they significantly decreased PCT Na ϩ -K ϩ -ATPase activity (Fig. 3B) .
We have previously shown that renal effects of PRL require an intact renal dopamine system (17) . Permissive and synergistic effects can be explained by heterologous receptor recruitment to the plasma membrane, where the receptors become physiologically active (14) . Two complementary techniques were used to examine whether PRL was able to recruit D1 receptors to the plasma membrane: subcellular fractionation of the outer renal cortex and cell surface biotinylation using primary cultured proximal tubular cells. Na
-ATPase is generally used as a plasma membrane marker. We confirmed that our subcellular fractionation resulted in Na ϩ -K ϩ -ATPase-enriched and -nonenriched fractions (Fig. 4A) . In the presence of PRL, the D1-like receptor abundance was increased in the Na ϩ -K ϩ -ATPase-enriched fraction and reduced in the Na ϩ -K ϩ -ATPase-nonenriched fraction (ratio Na ϩ -K ϩ -ATPase enriched/nonenriched, control: 0.73 Ϯ 0.14, PRL: 1.54 Ϯ 0.02) (Fig. 4A) . Using biotinylation techniques, we found that PRL significantly increased the amount of D1-like receptors inserted into the plasma membrane (Fig. 4B) .
Several lines of evidence suggest an association between hypertension and reduced activity in the renal dopamine system (3, 30) . The SHR has a blunted response to dopamine, which can be attributed to reduced D1-like receptor responsiveness (20, 28) . To confirm the importance of the renal dopamine system in mediating the renal effects of PRL, we studied the effect of PRL on PCT Na ϩ -K ϩ -ATPase activity isolated from SHR and their normotensive control WKY rats. PRL significantly decreased PCT Na ϩ -K ϩ -ATPase activity in WKY rats, but had no such effect on PCT Na ϩ -K ϩ -ATPase activity in SHR (Fig. 5) .
DISCUSSION
Dopamine is well established as an intrarenal natriuretic hormone (3). PRL has also been shown to have a natriuretic effect (17, 25, 27) . In a previous paper, we showed that in vivo treatment of SD rats with PRL resulted in a ninefold increase in urinary sodium excretion, without any effect on glomerular filtration rate or blood pressure. This natriuretic response was associated with kaliuresis, suggesting that the proximal tubule Ϫ5 M (JAK 2 inhibitor); dopamine (DA; 10 Ϫ6 M). SD rat PCT were preincubated with indicated inhibitors for 10 min before PRL or DA was added for 15 and 30 min, respectively; n ϭ 3-10 rats. *P Ͻ 0.05 vs. control. **P Ͻ 0.05 vs. PRL. ***P Ͻ 0.05 vs. control and vs. PRL. Not significant (NS) vs. DA.
is the major site of action of PRL. We also found that PRL dose dependently decreased proximal tubule Na ϩ -K ϩ -ATPase activity in microdissected PCT. Both the in vivo and the in vitro effects of PRL were abolished by a D1-like receptor antagonist. L-Dopa, the renal precursor to dopamine, is transported into the tubular cell, were it is converted to dopamine by aromatic amino acid decarboxylase (AADC). The L-dopa level in microdissected proximal tubular segments is high enough to produce dopamine (19) . We found that PRL had no effect on Na ϩ -K ϩ -ATPase activity in tubules pretreated with inhibitors of AADC. Taken together, these results suggested that the renal dopamine system has a permissive role for PRL (17) . Results from the current study further strengthen this assumption. Here, we report that dopamine and PRL share signaling pathways and that the permissive role of the renal dopamine system for PRL is explained by a heterologous D1-like receptor recruitment to the plasma membrane.
Dopamine decreases Na ϩ -K ϩ -ATPase activity through a complex signaling pathway. Activation of PCT D1-like receptors results in a cAMP-mediated recruitment of D1-like receptors from the interior of the cell to the plasma membrane, where they become physiologically active (6) . This D1-like receptor recruitment is required for PKC activation and translocation to the plasma membrane (21) . Dopamine mediates both PKA-and PKC-dependent phosphorylation of the catalytic ␣-subunit of Na ϩ -K ϩ -ATPase (4, 11, 13) . PKA-induced phosphorylation of Ser-943 enhances PKC-induced inhibition of Na ϩ -K ϩ -ATPase activity (8) . In addition, dopamine-induced inhibition of Na ϩ -K ϩ -ATPase includes an activation of PI 3-K and a probable dimerization with Na ϩ -K ϩ -ATPase (9, 29) . Herein, we found that PRL signaling pathways appear to be identical to dopamine signaling pathways in PCT, including PKA activation, PKC phosphorylation of renal cortical Na ϩ -K ϩ -ATPase, and coimmunoprecipitation of Na ϩ -K ϩ -ATPase and PI 3-K. PRL has been shown to activate PI 3-K via Src, via an insulin receptor substrate (IRS) and via the G proteincoupled ␤2-adrenergic receptor (12, 16, 24) . Here, we showed that PRL-induced coimmunoprecipitation of PI 3-K and Na ϩ -K ϩ -ATPase was mediated via the D1-like receptor. The inhibitory effects of ANP and isoproterenol on Na ϩ -K ϩ -ATPase activity require an intact renal dopamine system Fig. 2 . PKC phosphorylation and PI 3-K-Na ϩ -K ϩ -ATPase coimmunoprecipitation. A: effect of PRL on Ser-23 phosphorylation site of Na ϩ -K ϩ -ATPase. Top: representative Western blots. Ser-23-dephosphorylated Na ϩ -K ϩ -ATPase ␣1-subunit was visualized by a specific antibody. Total (nonphosphorylated and Ser-23 phosphorylated) Na ϩ -K ϩ -ATPase ␣1-subunit was visualized by a commercially available antibody. PRL, 1 g/ml, n ϭ 7 rats; DA, 10 Ϫ6 M, n ϭ 1 rat. B: effect of PRL on PI 3-K and Na ϩ -K ϩ -ATPase dimerization. Top: representative Western blots. PRL, 1 g/ml; DA, D1-like receptor agonist SKF S143 (10 Ϫ5 M); SCH 23390 (10 Ϫ6 M), n ϭ 3-6 rats. *P Ͻ 0.05 vs. control. **P Ͻ 0.05 vs. PRL. #P Ͻ 0.05 vs. control. Fig. 3 . Synergism between PRL and dopamine on Na ϩ -K ϩ -ATPase activity. A: maximal doses of PRL and DA. PRL, 1 g/ml and DA, 10 Ϫ5 M, were used for 15-min incubation of SD rat PCT; n ϭ 3 rats. *P Ͻ 0.05 vs. control. **P Ͻ 0.05 vs. control and vs. PRL. B: subthreshold doses of PRL and DA. PRL, 1 ng/ml and DA, 10 Ϫ8 M, were used for 15-min incubation of SD rat PCT; n ϭ 5 rats. *P Ͻ 0.05 vs. control, vs. PRL, and vs. DA.
and are associated with a heterologous recruitment of D1-like receptors to the plasma membrane (7, 14) . Furthermore, subthreshold doses of ANP and dopamine, and isoproterenol and dopamine, have a synergistic effect on Na ϩ -K ϩ -ATPase activity. These effects can be attributed to heterologous recruitment of D1-like receptors to the plasma membrane (7, 14) . PRL interacts with dopamine in a similar way; its effect on Na ϩ -K ϩ -ATPase activity requires an intact dopamine system, subthreshold doses of PRL and dopamine have a synergistic effect, and PRL induces a heterologous recruitment of D1-like receptors from the interior of the cell into the plasma membrane.
The PRLR is a plasma membrane-anchored monomeric protein. Upon ligand binding, two PRLR dimerize and JAK-2 is activated (12) . JAK-2 activation results in phosphorylation of several intracellular proteins (12, 5) . Besides JAK-2 activation, PRL and dopamine signal via similar pathways in renal PCT. Whether one or more of the JAK-2-phosphorylated proteins participate in D1-like receptor recruitment to the plasma membrane is an interesting topic for further studies.
PRL is a potent natriuretic peptide. This effect is associated with an inhibition of PCT Na ϩ -K ϩ -ATPase activity. The renal effects of PRL are abolished during inhibition of renal dopamine synthesis as well as by a D1-like receptor antagonist. Blockage of the D2-like receptors does not prevent PRLinduced inhibition of Na ϩ -K ϩ -ATPase activity (17) . The hypertensive rat strain SHR has a blunted response to dopamine. This effect can be attributed to decreased D1-like receptor responsiveness (20, 30) . Here, we found that the response to PRL on Na ϩ -K ϩ -ATPase activity was blunted in SHR. The lack of PRL effect in SHR emphasizes the role of PRL interacting with dopamine but does not rule out a possible defect in PRLR in the SHR. This question deserves further investigations. We conclude that dopamine has a central role in the interactive regulation of salt homeostasis. Not only G proteincoupled receptors but also a classic tyrosine receptor, the PRLR, exert its salt-regulating effect by heterologous recruitment and the associated activation of renal D1-like receptors. Fig. 5 . Effects of PRL on Na ϩ -K ϩ -ATPase activity in PCT isolated from spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats. PRL (1 g/ml) was used for 15-min incubation of SHR and WKY rat PCT; n ϭ 5 rats/group. *P Ͻ 0.05 vs. WKY control; NS vs. SHR control. Hypothetically, heterologous receptor recruitment may be one explanation for cross talk between signaling pathways mediated by tyrosine kinase receptors and G protein-coupled receptors.
